Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Cord Blood Stem Cells

Cardiovascular toxicity of cryopreserved cord blood cell infusion

Abstract

Although infusion of cryopreserved bone marrow or peripheral blood stem cell is associated with a variety of symptoms, there have been no reports detailing the data of infusion-related toxicities of cryopreserved cord blood (CB) units. We prospectively evaluated the incidence and significance of infusion-related toxicities in 34 adult patients undergoing unrelated CB transplantation. Cryopreserved CB units were thawed and immediately infused, unfiltered, through a central intravenous catheter without further manipulation. Heart rate, blood pressure, oxygen saturation and clinical symptoms were recorded during and after infusion. Twenty-four percent of patients experienced non-cardiovascular toxicities related to infusion. The incidence of systolic and diastolic hypertension and bradycardia was 58, 64 and 32%, respectively. Although three patients (9%) with severe systolic hypertension after the infusion required treatment with antihypertensive agents, no patients experienced life-threatening side effects or needed discontinuation of CB unit infusion. Patient or transplant characteristics had no effect on the hypertension and bradycardia related to the infusion of CB. These data suggest that infusion of cryopreserved CB without further manipulation after thawing is safe and well tolerated. However, cardiovascular toxicities including hypertension and bradycardia were frequently observed.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Rubinstein P, Carrier C, Scaradavou A, Kurtzberg J, Adamson J, Migliaccio AR et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998; 339: 1565–1577.

    Article  CAS  PubMed  Google Scholar 

  2. Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Champlin RE et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 2004; 351: 2265–2275.

    Article  CAS  PubMed  Google Scholar 

  3. Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Bosi A et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 2004; 351: 2276–2285.

    Article  CAS  PubMed  Google Scholar 

  4. Takahashi S, Iseki T, Ooi J, Tomonari A, Takasugi K, Shimohakamada Y et al. Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies. Blood 2004; 104: 3813–3820.

    Article  CAS  PubMed  Google Scholar 

  5. Takahashi S, Ooi J, Tomonari A, Konuma T, Tsukada N, Oiwa-Monna M et al. Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem cell transplantation from related donors in adult patients with hematological malignancies after myeloablative conditioning regimen. Blood 2007; 109: 1322–1330.

    Article  CAS  PubMed  Google Scholar 

  6. Ooi J, Iseki T, Takahashi S, Tomonari A, Takasugi K, Shimohakamada Y et al. Unrelated cord blood transplantation for adult patients with de novo acute myeloid leukemia. Blood 2004; 103: 489–491.

    Article  CAS  PubMed  Google Scholar 

  7. Rubinstein P, Dobrila L, Rosenfield RE, Adamson JW, Migliaccio G, Migliaccio AR et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci USA 1995; 92: 10119–10122.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Sauer-Heilborn A, Kadidlo D, McCullough J . Patient care during infusion of hematopoietic progenitor cells. Transfusion 2004; 44: 907–916.

    Article  PubMed  Google Scholar 

  9. Davis JM, Rowley SD, Braine HG, Piantadosi S, Santos GW . Clinical toxicity of cryopreserved bone marrow graft infusion. Blood 1990; 75: 781–786.

    CAS  PubMed  Google Scholar 

  10. Zambelli A, Poggi G, Da Prada G, Pedrazzoli P, Cuomo A, Miotti D et al. Clinical toxicity of cryopreserved circulating progenitor cells infusion. Anticancer Res 1998; 18: 4705–4708.

    CAS  PubMed  Google Scholar 

  11. Stroncek DF, Fautsch SK, Lasky LC, Hurd DD, Ramsay NK, McCullough J . Adverse reactions in patients transfused with cryopreserved marrow. Transfusion 1991; 31: 521–526.

    Article  CAS  PubMed  Google Scholar 

  12. Donmez A, Tombuloglu M, Gungor A, Soyer N, Saydam G, Cagirgan S . Clinical side effects during peripheral blood progenitor cell infusion. Transfus Apher Sci 2007; 36: 95–101.

    Article  PubMed  Google Scholar 

  13. Alessandrino P, Bernasconi P, Caldera D, Colombo A, Bonfichi M, Malcovati L et al. Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases. Bone Marrow Transplant 1999; 23: 533–537.

    Article  CAS  PubMed  Google Scholar 

  14. Milone G, Mercurio S, Strano A, Leotta S, Pinto V, Battiato K et al. Adverse events after infusions of cryopreserved hematopoietic stem cells depend on non-mononuclear cells in the infused suspension and patient age. Cytotherapy 2007; 9: 348–355.

    Article  CAS  PubMed  Google Scholar 

  15. Styler MJ, Topolsky DL, Crilley PA, Covalesky V, Bryan R, Bulova S et al. Transient high grade heart block following autologous bone marrow infusion. Bone Marrow Transplant 1992; 10: 435–438.

    CAS  PubMed  Google Scholar 

  16. Keung YK, Lau S, Elkayam U, Chen SC, Douer D . Cardiac arrhythmia after infusion of cryopreserved stem cells. Bone Marrow Transplant 1994; 14: 363–367.

    CAS  PubMed  Google Scholar 

  17. López-Jiménez J, Cerveró C, Muñoz A, Hernández-Madrid A, Fernández Pineda J, García Laraña J et al. Cardiovascular toxicities related to the infusion of cryopreserved grafts: results of a controlled study. Bone Marrow Transplant 1994; 13: 789–793.

    PubMed  Google Scholar 

  18. Calmels B, Lemarie C, Esterni B, Malugani C, Charbonnier A, Coso D et al. Occurrence and severity of adverse events after autologous hematopoietic progenitor cell infusion are related to the amount of granulocytes in the apheresis product. Transfusion 2007; 47: 1268–1275.

    Article  PubMed  Google Scholar 

  19. Nagamura-Inoue T, Shioya M, Sugo M, Cui Y, Takahashi A, Tomita S et al. Wash-out of DMSO does not improve the speed of engraftment of cord blood transplantation: follow-up of 46 adult patients with units shipped from a single cord blood bank. Transfusion 2003; 43: 1285–1294.

    Article  PubMed  Google Scholar 

  20. Donmez A, Zoghi M, Cagirgan S, Acarlar C, Tombuloglu M . The effect of hematopoietic progenitor cells' temperature on cardiac arrhythmias in patients given peripheral blood progenitor cells. Transfus Apher Sci 2006; 34: 245–251.

    Article  PubMed  Google Scholar 

  21. McKenna DH, Wagner JE, McCullough JJ . Umbilical cord blood infusions are associated with mild reactions and are overall well-tolerated. Cytotherapy 2003; 5: 438 (abstr. 11).

    Article  Google Scholar 

  22. Hahn T, Bunworasate U, George MC, Bir AS, Chinratanalab W, Alam AR et al. Use of nonvolume-reduced (unmanipulated after thawing) umbilical cord blood stem cells for allogeneic transplantation results in safe engraftment. Bone Marrow Transplant 2003; 32: 145–150.

    Article  CAS  PubMed  Google Scholar 

  23. Petropoulou AD, Bellochine R, Norol F, Marie JP, Rio B . Coronary artery spasm after infusion of cryopreserved cord blood cells. Bone Marrow Transplant 2007; 40: 397–398.

    Article  CAS  PubMed  Google Scholar 

  24. Syme R, Bewick M, Stewart D, Porter K, Chadderton T, Glück S . The role of depletion of dimethyl sulfoxide before autografting: on hematologic recovery, side effects, and toxicity. Biol Blood Marrow Transplant 2004; 10: 135–141.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank the medical and nursing staff for taking care of the patients in this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J Ooi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Konuma, T., Ooi, J., Takahashi, S. et al. Cardiovascular toxicity of cryopreserved cord blood cell infusion. Bone Marrow Transplant 41, 861–865 (2008). https://doi.org/10.1038/sj.bmt.1705993

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705993

Keywords

This article is cited by

Search

Quick links